Mounjaro 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FM1QD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,435
Award facts
- Contract value 100% obligated
- $10,435.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 2.5 mg/0.5 mL pen injections, a diabetes medication used for glycemic control and weight management. This firm fixed-price delivery order was awarded on September 22, 2025, with a ceiling value of $10,435.24 and an ultimate completion date of September 23, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's substantial IDC with DLA demonstrates its capability to meet federal procurement requirements through open competition and manage diverse medical supply portfolios across multiple therapeutic domains. This delivery order for Mounjaro represents one of numerous pharmaceutical procurements the company fulfills through its DLA contract vehicle, supporting the Defense Health Agency and other government healthcare systems with brand-name medications, generics, vaccines, and specialized medical supplies.
Quick answers
Who was awarded contract SPE2DB25FM1QD?
SPE2DB25FM1QD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FM1QD worth?
The government has obligated $10,435 on SPE2DB25FM1QD.
Is contract SPE2DB25FM1QD an order under another contract?
Yes. SPE2DB25FM1QD is a delivery order under SPE2DB22D2009, an indefinite delivery contract.
Was contract SPE2DB25FM1QD competed?
The extent of competition for SPE2DB25FM1QD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award